CompletedNCT02203552
Minocycline for Depression and Anxiety During Breast Cancer Chemotherapy
About this title
Read the official source — NCT02203552Medication studyAges 18+United States
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- ColumbusSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: June 23, 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 56
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT02203552
- Official title
Show the full official title
Randomized Placebo Controlled Study of Minocycline for Amelioration of Chemotherapy Induced Affective Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Columbus
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Ohio State University Comprehensive Cancer Center, a university.
Did this study involve medication?
Yes. The study involved medication, including minocycline hydrochloride.
Who was this study for?
Listed age limits: from 18 years.
